Email Updates

Search form

You are here

Study of Immune Responses Induced by a HIV Vaccine (RV328)

Status
Ongoing
Phase
II
Principal Investigator(s)
Nittaya Phanuphak
Objective

The purpose of this study is to define the immune responses induced by a HIV vaccine, AIDSVAX B/E. Blood and mucosal samples will be collected to assess immune responses.

Prevention Option(s)
HIV Vaccine
Study Design
Randomized
Double-blind
Arms and Assigned Interventions
Description
AIDSVAX B/E at Weeks 0, 4, 24 and 48
Products
AIDSVAX
ARMs
Experimental
Description
AIDSVAX B/E Placebo at Weeks 0, 4, 24 and 48
ARMs
Placebo Comparator
Trial Sponsors
U.S. Army Medical Research and Materiel Command, NIH
July 2014
February 2017
Enrollment
40
20
Years
40
Years
Population
Women
Men
Sites

Thai Red Cross AIDS Research Centre

Bangkok
Thailand